G6PD deficiency in Plasmodium falciparum and Plasmodium vivax malaria-infected Cambodian patients
Open Access
- 28 May 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in Malaria Journal
- Vol. 12 (1), 171-10
- https://doi.org/10.1186/1475-2875-12-171
Abstract
Background: Glucose-6-phosphate-dehydrogenase deficiency (G6PDd) rates are unknown in malaria-infected Cambodian patients. These data are key to a rational drug policy for malaria elimination ofPlasmodium falciparumandPlasmodium vivax.Methods: From September 2010–2012, a two-year survey of G6PDd and haemoglobinopathies assessed by quantitative enzyme activity assay and haemoglobin electrophoresis, respectively, was conducted in malaria-infected patients presenting to 19 health centres throughout Cambodia.Results: A total of 2,408 confirmed malaria patients of mean age 26.7 (range 2–81) years were recruited from mostly western Cambodia (n = 1,732, 71.9%); males outnumbered females by 3.9:1.Plasmodium falciparumwas present in 1,443 (59.9%) andP. vivaxin 965 (40.1%) patients. Mean G6PD activity was 11.6 (CI 95%: 11.4-11.8) U/g Hb, G6PDd was present in 13.9% of all patients (335/2,408) and severe G6PDd (including WHO Class I and II variants) was more common in western (158/1,732, 9.1%)versuseastern (21/414, 5.1%) Cambodia (P = 0.01). Of 997/2,408 (41.4%) had a haemoglobinopathy. Mean haemoglobin concentrations were inversely related to age: 8.1 g/dL < five years, 8.7 g/dL five to 14 years, and 10.4 g/dL >15 years (P <0.001).Conclusions: G6PDd prevalence, anaemia and haemoglobinopathies were common in malaria-infected patients. The deployment of primaquine in Cambodia should be preceded by primaquine safety studies paralleled with evaluations of easy to use tests to detect G6PDd.Keywords
This publication has 32 references indexed in Scilit:
- Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop reportMalaria Journal, 2013
- Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of September 2012 meetingMalaria Journal, 2012
- G6PD Deficiency Prevalence and Estimates of Affected Populations in Malaria Endemic Countries: A Geostatistical Model-Based MapPLoS Medicine, 2012
- Focused Screening and Treatment (FSAT): A PCR-Based Strategy to Detect Malaria Parasite Carriers and Contain Drug Resistant P. falciparum, Pailin, CambodiaPLOS ONE, 2012
- Optimising Strategies for Plasmodium falciparum Malaria Elimination in Cambodia: Primaquine, Mass Drug Administration and Artemisinin ResistancePLOS ONE, 2012
- Global malaria mortality between 1980 and 2010: a systematic analysisThe Lancet, 2012
- Performance of the CareStart™ G6PD Deficiency Screening Test, a Point-of-Care Diagnostic for Primaquine Therapy ScreeningPLOS ONE, 2011
- In Tanzania, Hemolysis after a Single Dose of Primaquine Coadministered with an Artemisinin Is Not Restricted to Glucose-6-Phosphate Dehydrogenase-Deficient (G6PD A−) IndividualsAntimicrobial Agents and Chemotherapy, 2010
- The role of anti-malarial drugs in eliminating malariaMalaria Journal, 2008
- A Randomised Trial of an Eight-Week, Once Weekly Primaquine Regimen to Prevent Relapse of Plasmodium vivax in Northwest Frontier Province, PakistanPLOS ONE, 2008